Key result
A case analysis of a poly-drug overdose led to a proposed treatment algorithm for mixed serotonin syndrome and neuroleptic malignant syndrome using cyproheptadine and dantrolene.
Why the study?
Does a specific treatment algorithm using cyproheptadine and dantrolene while avoiding initial bromocriptine or chlorpromazine improve management of mixed serotonin syndrome and neuroleptic malignant syndrome?
Case Report (n=1)
Does a specific treatment algorithm using cyproheptadine and dantrolene while avoiding initial bromocriptine or chlorpromazine improve management of mixed serotonin syndrome and neuroleptic malignant syndrome?
A practical algorithm for undifferentiated SS/NMS in critical care involves prompt use of cyproheptadine and dantrolene while avoiding agents that could exacerbate either condition.
No takes yet. Share an insight, caveat, or question.
Case-derived algorithm for mixed SS/NMS should not yet change practice; leaves open whether cyproheptadine plus dantrolene improves outcomes.
Kaufman et al. (2006) conducted a case report in Serotonin syndrome and neuroleptic malignant syndrome (n=1). Treatment algorithm (cyproheptadine and dantrolene) was evaluated. A case analysis of a poly-drug overdose led to a proposed treatment algorithm for mixed serotonin syndrome and neuroleptic malignant syndrome using cyproheptadine and dantrolene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: